138 related articles for article (PubMed ID: 28231366)
1. Comparison of cidofovir and the measles, mumps, and rubella vaccine in the treatment of recurrent respiratory papillomatosis.
Meacham RK; Thompson JW
Ear Nose Throat J; 2017 Feb; 96(2):69-74. PubMed ID: 28231366
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis.
Valera F; Maldonato L; Lima J; Küpper DS; Lacerda RN; Mamede R; Ricz H
Braz J Otorhinolaryngol; 2010; 76(6):713-7. PubMed ID: 21180938
[TBL] [Abstract][Full Text] [Related]
3. Intralesional cidofovir injection for recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshizaki T
Auris Nasus Larynx; 2016 Oct; 43(5):541-5. PubMed ID: 26860235
[TBL] [Abstract][Full Text] [Related]
4. Experimental research on the therapeutic effect of MMR vaccine to juvenile-onset recurrent respiratory papillomatosis.
Wang Y; Dai PD; Zhang TY
Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):801-803. PubMed ID: 30806807
[TBL] [Abstract][Full Text] [Related]
5. Experience of 11 years use of cidofovir in recurrent respiratory papillomatosis.
Graupp M; Gugatschka M; Kiesler K; Reckenzaun E; Hammer G; Friedrich G
Eur Arch Otorhinolaryngol; 2013 Feb; 270(2):641-6. PubMed ID: 23070260
[TBL] [Abstract][Full Text] [Related]
6. Intralesional cidofovir for pediatric recurrent respiratory papillomatosis.
Mandell DL; Arjmand EM; Kay DJ; Casselbrant ML; Rosen CA
Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1319-23. PubMed ID: 15545589
[TBL] [Abstract][Full Text] [Related]
7. Cidofovir efficacy in recurrent respiratory papillomatosis: a randomized, double-blind, placebo-controlled study.
McMurray JS; Connor N; Ford CN
Ann Otol Rhinol Laryngol; 2008 Jul; 117(7):477-83. PubMed ID: 18700421
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
9. The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis.
Mikolajczak S; Quante G; Weissenborn S; Wafaisade A; Wieland U; Lüers JC; Klussmann JP; Beutner D
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2543-8. PubMed ID: 22766836
[TBL] [Abstract][Full Text] [Related]
10. Treatment of paediatric laryngeal papillomas: web survey of British Association of Paediatric Otolaryngologists.
Manickavasagam J; Wu K; Bateman ND
J Laryngol Otol; 2013 Sep; 127(9):917-21. PubMed ID: 23927772
[TBL] [Abstract][Full Text] [Related]
11. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
12. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
Peyton Shirley W; Wiatrak B
Int J Pediatr Otorhinolaryngol; 2004 Apr; 68(4):413-8. PubMed ID: 15013606
[TBL] [Abstract][Full Text] [Related]
13. Intralesional injection of cidofovir for recurrent respiratory papillomatosis in children.
Bielecki I; Mniszek J; Cofała M
Int J Pediatr Otorhinolaryngol; 2009 May; 73(5):681-4. PubMed ID: 19193450
[TBL] [Abstract][Full Text] [Related]
14. Intermediate-term and long-term results after treatment by cidofovir and excision in juvenile laryngeal papillomatosis.
Naiman AN; Ayari S; Nicollas R; Landry G; Colombeau B; Froehlich P
Ann Otol Rhinol Laryngol; 2006 Sep; 115(9):667-72. PubMed ID: 17044537
[TBL] [Abstract][Full Text] [Related]
15. Trends in the management of recurrent respiratory papillomatosis in Japan.
Murono S; Nakanishi Y; Tsuji A; Endo K; Kondo S; Wakisaka N; Yoshida H; Yoshizaki T
Auris Nasus Larynx; 2015 Jun; 42(3):218-20. PubMed ID: 25454156
[TBL] [Abstract][Full Text] [Related]
16. Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients.
Tjon Pian Gi RE; Ilmarinen T; van den Heuvel ER; Aaltonen LM; Andersen J; Brunings JW; Chirila M; Dietz A; Ferran Vilà F; Friedrich G; de Gier HH; Golusinski W; Graupp M; Hantzakos A; Horcasitas R; Jackowska J; Koelmel JC; Lawson G; Lindner F; Remacle M; Sittel C; Weichbold V; Wierzbicka M; Dikkers FG
Eur Arch Otorhinolaryngol; 2013 May; 270(5):1679-87. PubMed ID: 23377227
[TBL] [Abstract][Full Text] [Related]
17. Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.
Donne AJ; Rothera MP; Homer JJ
Int J Pediatr Otorhinolaryngol; 2008 Jul; 72(7):939-44. PubMed ID: 18502519
[TBL] [Abstract][Full Text] [Related]
18. Topical measles-mumps-rubella vaccine in the treatment of recurrent respiratory papillomatosis: results of a preliminary randomized, controlled trial.
Lei J; Yu W; Yuexin L; Qi C; Xiumin S; Tianyu Z
Ear Nose Throat J; 2012 Apr; 91(4):174-5. PubMed ID: 22522357
[TBL] [Abstract][Full Text] [Related]
19. Intralesional Cidofovir application in recurrent laryngeal papillomatosis.
Pudszuhn A; Welzel C; Bloching M; Neumann K
Eur Arch Otorhinolaryngol; 2007 Jan; 264(1):63-70. PubMed ID: 17058091
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
Lee AS; Rosen CA
J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
